Diltiazem Hci Injection, Powder, Lyophilized, For Solution
Product Images NDC 51662-1457

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Diltiazem Hci (NDC 51662-1457). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dosage (Dosage)

This is a description for Diltiazem Hydrochloride Injection used for patients. It comes in different quantities and concentrations for final administration. The injection is administered through infusion and the dosage varies based on the patient's condition. It is given with the appropriate volume and rates as specified in the text. A reasonable dose may be 5mg/h, although this may differ from patient to patient. There is also an ADD-Vantage vial for a 100mg dose.*

FDA Label Image

How Supplied 1 (How Supplied 1)

This text describes the unit of sale and concentration for two types of medication available in single-dose fliptop vials. The first medication is 25mg/5mL and the second medication is 50mg/10mL. Both medications come in a carton of 10 vials and have an NDC code of 0409-1171. The vials are also available separately in 5mL and 10mL sizes.*

FDA Label Image

How Supplied 2 (How Supplied 2)

The text describes the unit of sale for a medication with NDC code 0409-4350-03 and 0409-4350-13, which is a tray containing 10 ADD-100mg/ADD-Vantage Vials.*

FDA Label Image

Figure 1 And 2 (Inst 1)

FDA Label Image

Figure 3 And 4 (Inst 2)

FDA Label Image

Figure 5 And 6 (Inst 3)

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Vial Labeling (Serialized Labeling)

Single-dose sterile vial containing 100 mg Diltiazem HCI, suitable for continuous intravenous infusion, distributed by HF Acquisition Co., LLC in Mukilteo, WA 98275. Each vial contains lyophilized powder with 75mg Mannitol USP. Instructions for dosage are provided in the manufacturer's package insert.*

FDA Label Image

Structure (Structure)

FDA Label Image

Label Opt. 1 (Vial Label Opt 1)

This is a description of a medication called Diltiazem HCI for Injection. It is a single-dose sterile powder with an NDC code of 0409-4350-13 and is meant for continuous intravenous infusion only, and not for bolus. Each vial contains 100mg of Diltiazem hydrochloride and 75mg of Mannitol USP in a lyophilized powder format. The medication must be stored at 20 to 25°C prior to reconstitution. The usual dosage is mentioned on the insert provided. The medication is manufactured by Hospira, Inc. located in Lake Forest, IL 60045 USA. The text mentions RL-6973.*

FDA Label Image

Vial Label Opt. 2 (Vial Label Opt. 2)

ADD-Vantage® Vial Sterile Powder is a single-use container with Diltiazem HCI for injection. It should be stored at a temperature between 20 to 25°C (68 to 77°F), and it shouldn't be frozen or used for bolus. After reconstitution, the material should remain stable for 24 hours at a controlled room temperature of 2 to 8°C. Each vial consists of lyophilized powder comprising 100mg diltiazem hydrochloride and 75mg Mannitol USP.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.